310 Results (Page 7 of 13)
Italy Markets Research Reports
Italy Myasthenia Gravis Drugs Market Analysis
Italy Myasthenia Gravis Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. The market for myasthenia gravis is rising due to increasing prevalence and incidence of disease, improved diagnostic techniques, increased awareness and better understanding of the disease, Supportive Government Initiatives like providing financial support, improving healthcare infrastructure, promoting research in rare diseases and Technological Advancements in drugs and therapies treating myasthenia gravis. Major global players in Myasthenia Gravis Drugs Market are Alexion Pharmaceuticals, Inc., Bausch Health Companies, Inc., Novartis AG, Amneal Pharmaceuticals LLC, Zydus Cadila, Avadel, Dr. Reddy's Laboratories, Ltd., Fresenius Kabi, AG, Endo Pharmaceuticals, Inc., Amphastar Pharmaceuticals, Inc., Mylan N.V., Aurobindo Pharma, Pfizer, Inc., Astellas Pharma, Inc.
Italy Neuromyelitis Optica Spectrum Disorder (NMOSD) Drugs Market Analysis
Italy Neuromyelitis Optica Spectrum Disorder (NMOSD) Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. Increasing awareness and diagnosis, Increasing funding for medical infrastructure and high rate of multiple sclerosis prevalence (MS), unmet medical needs, advancements in drug development, Regulatory Approvals of drugs like eculizumab, inebilizumab and satralizumab , rising healthcare expenditure and growing collaborations in research and development of drugs are the major drivers for Neuromyelitis Optica Spectrum Disorder (NMOSD) drugs Market. Major global players in Neuromyelitis Optica Spectrum Disorder (NMOSD) drugs Market are F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), Pfizer Inc. (U.S.), GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Zydus Cadila (India), Boehringer Ingelheim International GmbH. (Germany), Apotex Inc. (Canada), AstraZeneca (U.K.), Horizon Therapeutics PLC (Ireland), Johnson & Johnson Private Limited (U.S.), Bayer AG (Germany), Sun Pharmaceutical Industries Ltd. (India), LEO Pharma A/S (Denmark).
Italy Oculopharyngeal Muscular Dystrophy (OPMD) Market Analysis
Italy Oculopharyngeal Muscular Dystrophy (OPMD) market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Oculopharyngeal Muscular Dystrophy (OPMD)is growing due to increase spending in research and development activities by pharmaceutical companies, incentives provided by regulatory authorities like orphan drug designations and accelerated approval pathways, patient support and advocacy programmes which help to increase awareness about disease and provide support to patients. Bristol-Myers Squibb, BioMarin, Sarepta Therapeutics, Benitec Biopharma Inc., Bioblast Pharma, PTC Therapeutics, NS Pharma, Nobelpharma Co., Ltd ,Santhera Pharmaceuticals, Pfizer Inc. ,Marathon Pharmaceuticals, Fibrogen, GSK are the key global market players.
Italy POMC Genetic Obesity Drugs Market Analysis
Italy POMC Genetic Obesity Drugs market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for POMC Genetic Obesity Drugs is growing due to increase spending in research and development activities by pharmaceutical companies, introduction of new emerging therapies like gene editing and gene replacement approaches, incentives provided by regulatory body?s in the form of orphan drug designations. Novo Nordisk A/S , rhythm Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated ,Amgen Inc are the key market players operating in global POMC genetic obesity drugs market.
Italy Pompe Disease Drugs Market Analysis
Italy Pompe Disease Drugs market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Pompe disease Drugs is growing due to increase in awareness about the disease , better diagnosis, advancements in treatment options and increase in research and development activities by different pharmaceutical companies and research organizations. Sanofi Genzyme ,BioMarin Pharmaceutical Inc., Avrobio Inc., Amicus Therapeutics Inc. are the key market players operating in global pompe disease market.
Italy Primary Hyperoxaluria (PH) Drugs Market Analysis
Italy Primary Hyperoxaluria (PH) Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. Unmet Medical Need, Increasing Awareness and Diagnosis, Advancements in Research and Development, Growing Investment and Pipeline Development, Collaboration and Patient Advocacy,rise in the number of persons with the condition worldwide. The regulatory body's extension of special designations and rising consumer demand for medications including thiazide diuretics, calcium oxalate urinary inhibitors, and others to address a variety of health issues both contribute to the market's quick growth. Major global players in Primary Hyperoxaluria (PH) Drugs Market are Allena Pharmaceuticals, Inc., Intellia Drugs, Inc., OxThera, Dicerna Pharmaceuticals, Inc, Alnylam Pharmaceuticals, Inc., Pfizer Inc., and Sanofi.
Italy Pyruvate Kinase (PK) Deficiency Market Analysis
Italy Pyruvate Kinase (PK) deficiency market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Pyruvate Kinase (PK) deficiency is growing rapidly as a result of increase in incidence and prevalence of disease, increased awareness about the disease, improved diagnostic techniques, advancements in treatment options, increase in research and development and rise in patient assistance programmes. Agios pharmaceuticals, Pfizer Inc., Sanofi, Novartis, Teva Pharmaceutical Industries Ltd, Green cross corporation are the top key market players operating in the global Pyruvate Kinase (PK) deficiency market.
Italy Rare Hematology Disorders Market Analysis
Italy Rare Hematology Disorders market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Rare Hematology Disorders is growing rapidly as a result of increase in incidence of rare blood disorders, increase in awareness of rare hematology disorders, advancement in genetic testing and diagnostic techniques, increase in spending on healthcare infrastructure and increasing adoption of gene therapy. Sanofi Genzyme, Pfizer Inc., Novartis AG, Alexion Pharmaceuticals, Shire., BioMarin Pharmaceutical Inc., CSL Behring are the key global market players operating in rare hematology disorders market.
Italy Rare Hemophilia Factors Market Analysis
Italy Rare Hemophilia Factors market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Rare Hemophilia Factors is growing rapidly as a result of growing incidence of rare hemophilia factors deficiency, rising adoption of prophylactic treatments, growing awareness about rare hemophilia factors and their treatment options, rising demand for better and more effective therapies for rare hemophilia factors. Baxter, Bayer AG, Bio Products Laboratory Ltd., Novo Nordisk A/S, Alexion Pharmaceuticals, Amgen Inc, BioMarin, Amgen Inc are the key global market players operating in rare hemophilia factors market.
Italy Rett Syndrome Drugs Market Analysis
Italy Rett Syndrome Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. The market for Rett syndrome will grow over time as a result of expanding female population, rising public healthcare programme spending for patient advocacy and rising global healthcare expenditure. Major global players in Rett Syndrome Drugs Market are Merck KGaA (Germany), Eisai Co., Ltd. (Japan), AstraZeneca (U.K.), Sanofi (France), Novartis AG (Switzerland), Abbott (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Teva Pharmaceutical Industries Ltd. (Ireland), Pfizer Inc. (U.S.), GlaxoSmithKline plc (U.K.), WOCKHARDT (Mumbai), Novo Nordisk A/S (Denmark), Glenmark Pharmaceuticals Limited (India), Cipla Inc. (U.S.), Bausch Health Companies Inc. (Canada), Otsuka America Pharmaceutical, Inc. (U.S.), Johnson & Johnson Private Limited (U.S.), Takeda Pharmaceutical Company Limited (Japan), Sumitomo Corporation (Japan), Biocon (India)
Italy Sickle Cell Disease Drugs Market Analysis
Italy Sickle cell disease Drugs market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Sickle cell disease Drugs is growing rapidly as a result of increasing prevalence of sickle cell disease , increasing investment for healthcare infrastructure, increase in the number of research and development activities, Support provided by governments of different countries, patient advocacy programmes and incentives provided by regulatory authorities. Global Blood Therapeutics, Novartis, Emmaus Life Sciences, Bluebird Bio, Teva Pharmaceutical Industries Ltd, Pfizer Inc., Mylan N.V., Merck & Co., Inc., Johnson & Johnson Private Limited, Bristol-Myers Squibb Company, AbbVie Inc are the key global market players operating in sickle cell disease Drugs market.
Italy Soft Tissue Sarcoma Market Analysis
Italy Soft Tissue Sarcoma market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Soft Tissue Sarcoma is growing rapidly as a result of increasing prevalence and incidence of soft tissue sarcoma, rising awareness about the disease, rising research and development activities on drugs and other therapies, increase in partnerships between pharmaceutical companies for drug development and advancements in diagnostics. Pfizer Inc, Eli Lilly and Company, Johnson & Johnson, Bayer AG, Eisai Co., Ltd., Epizyme, Inc., Adaptimmune Therapeutics, Mylan N.V., Sanofi are the key market players operating in global Soft Tissue Sarcoma market.
Italy Wilson's Disease Drugs Market Analysis
Italy Wilson?s Disease Drugs market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Wilson?s Disease Drugs is growing rapidly as a result of rising prevalence of the disease, advancements in diagnostic techniques , increase in awareness about the disease due to patient advocacy programmes , support and incentives from regulatory authorities like incentives and orphan drug designations and increasing investment in research and development activities. Amneal Pharmaceuticals, Meda Pharmaceuticals, Teva Pharmaceuticals Industries Ltd. , Taj Pharmaceutical Limited, Ipsen Pharma, TSUMURA & CO., Mylan pharmaceuticals are the key global market players in wilson?s disease drugs market.
Italy X-Linked Myotubular Myopathy (XLMTM) Drugs Market Analysis
Italy X-Linked Myotubular Myopathy (XLMTM) Drugs market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for X-Linked Myotubular Myopathy (XLMTM) Drugs is growing rapidly as a result of unmet medical need for therapies of X-Linked Myotubular Myopathy (XLMTM) disease, advancements in gene therapy, Growing Awareness and Patient Advocacy about the disease, Increased Research and Collaboration between research organizations and pharmaceutical companies, supportive regulatory environments, Technological Advancements in gene sequencing and biomarker identification. Novartis Gene Therapies, Avrobio, Axovant Gene Therapies, Sarepta Therapeutics, Amicus Therapeutics, Sanofi Genzyme, Pfizer, Audentes Therapeutics are the key market players operating in global X-Linked Myotubular Myopathy (XLMTM) Drugs market.
Italy Oncolytic Virus Immunotherapy Market Analysis
Italy Oncolytic Virus Immunotherapy Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Oncolytic Virus Immunotherapy is expanding as a result of growing incidence of cancer. This growth is fueling the demand for better therapy solutions, thus, driving the growth of the Oncolytic Virus Immunotherapy market. Some of the key players in the global Oncolytic Virus Immunotherapy Market include Amgen, Inc., Oncolytics Biotech, Inc., Merck & Co., Inc., Transgene Biotek Ltd., Cold Genesys, Inc., SillaJen, Inc., Sorrento Therapeutics Inc., Shanghai Sunway Biotech Co. Ltd., Amgen Inc., TILT Biotherapeutics, Oncorus, Inc., Replimune Group, Inc., and Oncolys BioPharma, Inc.
Italy GMP Testing Service Market Analysis
Italy GMP Testing Service Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for GMP Testing Service is expanding as a result of rising demand of medical devices and increasing incidence of chronic illnesses. This demand is fueling the development of GMP Testing service market. Some of the key players in the global GMP Testing Service Market include Eurofins Scientific, PPD Inc., Microchem Laboratory, Sartorius AG, North American Science Associates Inc., Covance Inc., Nelson Laboratories LLC, Almac Group, Pace Analytical, Wuxi AppTec., Intertek Group PLC, and Charles River Laboratories.
Italy Health Care & Social Assistance Market Analysis
Italy Health Care & Social Assistance Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Health Care & Social Assistance is expanding as a result of growing geriatric population and investment in healthcare. This demand is fueling the development of better Health Care & Social Assistance services. Some of the key players in the global Health Care & Social Assistance Market include HCA Healthcare, CoxHealth, CommonSpirit Health, Trinity Health, TH Medical, HM Health Solutions Inc., UPMC, Sutter Health, Providence, Mayo Foundation for Medical Education and Research (MFMER), Quest Diagnostics Incorporates, Brookdale Senior Living Inc., Feeding America West Michigan, Trapollo, and Practice Fusion, Inc.
Italy Healthcare Electronic Data Interchange (EDI) Market Analysis
Italy Healthcare Electronic Data Interchange (EDI) Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Healthcare Electronic Data Interchange (EDI) is expanding as a result of increasing adoption of electronic systems and need for efficient healthcare data in both developed and developing nations. This demand is fueling the development of better software and methods for Healthcare Electronic Data Interchange (EDI). Some of the key players in the global Healthcare Electronic Data Interchange (EDI) Market include McKesson Corporation; Optum, Inc.; Athenahealth; Allscripts Healthcare, LLC; NXGN Management, LLC; Experian plc; Cognizant; Cerner Corporation.; SYNNEX Corporation.; Dell; The SSI Group, LLC; Waystar Health.; Comarch SA.; Axway; PLEXIS Healthcare Systems; Archer Software; B2BGateway; DiCentral.; 123 EDI; and Quadax, Inc.
Italy Healthcare Finance Solutions Market Analysis
Italy Healthcare Finance Solutions Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The Healthcare Finance Solutions market is expanding due to the continuous need for improvement in process and performance and the requirement for hi-tech equipment and technology in both developed and developing nations. This demand is fueling the requirement for efficient healthcare infrastructure. Some of the key players in the global Healthcare Finance Solutions Market include Koninklijke Philips N.V.; General Electric Company; Commerce Bancshares, Inc.; Siemens Financial Services, Inc.; Thermo Fisher Scientific; Stryker; Gemino Healthcare Finance; Oxford Finance LLC; TCF Capital Solutions; and CIT Group Inc.
Italy Healthcare In Vitro Diagnostic Market Analysis
Italy Healthcare In Vitro Diagnostic Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2033. The healthcare In Vitro Diagnostic Market is expanding as a result of the increasing prevalence of chronic and Infectious diseases. This demand is fueling the development of better diagnostic tools and methods for the early detection and accurate diagnosis of various diseases. Some of the key players in the global Healthcare In Vitro Diagnostic Market includes Abbott Laboratories, Becton, Dickinson and Company, bioM?rieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche AG, Siemens AG, QIAGEN N.V., Sysmex Corporation, Thermo Fisher Scientific, Inc.
Italy HIV Diagnostic Market Analysis
Italy HIV Diagnostics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for HIV diagnostics is expanding as a result of rising prevalence of the disease and increased blood transfusions. This demand is fueling the development of better diagnostic tools and methods for the early detection and accurate diagnosis of HIV. Some of the key players in the global HIV Diagnostics Market include Thermo-Fisher Scientific Inc., Hologic, Inc., Abbott, Alere Inc., Bio-Rad Laboratories, Inc., OraSure Technologies, Inc, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Chembio Diagnostics, Inc., Danaher Corporation, and Becton, Dickinson and Company.
Italy Hospital Acquired Infection (HAI) control Market Analysis
Italy Hospital Acquired Infection (HAI) Control Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Hospital Acquired Infection (HAI) Control is expanding as a result of rising population of elderly along with chronic diseases and growing prevalence of hospital acquired infections. This demand is fueling the development of better control methods for the hospital acquired infections. Some of the key players in the global Hospital Acquired Infection (HAI) Control Market include 3M Company, STERIS plc, Getinge AB, Advanced Sterilization Products, Ecolab Inc., MATACHANA GROUP, Belimed AG, Reckitt Benkiser, Contec Inc., Miele Group, and MMM Group.
Italy Hospital Information System Market Analysis
Italy Hospital Information System Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Hospital Information System is expanding as a result of rising government spending and implementation of healthcare IT solutions. This demand is fueling the development of better Hospital Information system for the efficient management of patient data. Some of the key players in the global Hospital Information System Market include Allscripts Healthcare, LLC, Cerner Corporation, Dedalus S. p. A., GE Healthcare, Integrated Medical Systems, Inc., Koninklijke Philips N.V., McKesson Corporation, NXGN Management, LLC, Siemens Healtineers AG, and Wipro Limited.
Italy Hospitals and Outpatient Care Centers Market Analysis
Italy Hospitals and Outpatient Care Centers Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Hospitals and Outpatient Care Centers is expanding as a result of rising demand for healthcare services and technological advancements. This demand is fueling the development of better Hospitals and Outpatient Care Centers. Some of the key players in the global Hospitals and Outpatient Care Centers Market include Kaiser Permanente, UnitedHealth Group Incorporated, HCA Healthcare, Tenet Healthcare, Fresenius Medical Care AG & Co. KGaA, Mayo Clinic, Community Health Systems, Cleveland Clinic, DaVita Inc., Ramsay Health Care, and Medtronic.
Italy ICU Beds Market Analysis
Italy ICU Beds Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for ICU Beds is expanding as a result of rising healthcare spending, growing geriatric population, and increasing prevalence of chronic diseases. This is boosting the growth of ICU Beds market. Some of the key players in the global ICU Beds Market Hill-Rom Holdings, Inc., Getinge AB, Linet Spol. S. R. O., Stiegelmeyer GmbH & Co. Kg, Stryker Corporation, Medline Industries, Inc., Invacare Corporation, Amico Corporation, Midmark Corporation, LINAK A/S, Melivaara Corp., and Nitrocare.
